October 06, 2026
Short answer: Over-the-counter retinol on the face is considered low risk while breastfeeding, because very little crosses the skin and it does not measurably change vitamin A levels in the blood (Nohynek 2006). Keep it off the breasts and anywhere the baby's skin or mouth touches, restart slowly on postpartum skin, and stop if you could be pregnant again. Prescription retinoids are a decision for your physician or pharmacist, and oral isotretinoin is not used while breastfeeding.
In pregnancy the concern is the developing embryo, which is exquisitely sensitive to vitamin A derivatives in the first trimester; oral isotretinoin causes serious birth defects, and topical retinoids are stopped as a precaution even though the accidental-exposure data are reassuring (Kaplan 2015). In breastfeeding the question is narrower: how much of what you apply reaches your bloodstream, then your milk, then your baby.
For retinoids applied to the face, the first step in that chain is already small. With radiolabelled tretinoin 0.05% cream, about 2% of the dose was absorbed after a single application and after 28 days of daily use, and 1.1% in people who had used it for over a year; plasma levels of tretinoin and its metabolites stayed within the range the body produces on its own (Latriano 1997). Cosmetic retinol behaves the same way. Women of child-bearing age who applied 0.3% retinol cream to about 3,000 cm², roughly a fifth of the body surface, every day for 21 days had no change in plasma retinol, retinyl esters or retinoic acids. A single oral dose of 10,000 IU of vitamin A, by contrast, raised them clearly (Nohynek 2006). An adult face is roughly 500 to 600 cm², a small fraction of that tested area.
Breast milk already contains vitamin A, because infants need it. The worry with a face serum is not that it adds a meaningful dose to that, but that there is no direct measurement: no study has tested milk after topical retinoid use. The reassurance is inferred from absorption data, which is why it is framed as low risk rather than proven safe.
Postpartum skin is often not the skin you had before pregnancy. Broken sleep, hormonal shifts and months without actives leave many people more reactive, and some are dealing with melasma that appeared during pregnancy (see what changes in pregnancy skin and why). Treat it as a fresh start rather than a return to your old dose:
Ask your physician or pharmacist before using prescription retinoids such as tretinoin, adapalene, tazarotene or trifarotene while breastfeeding; the choice depends on the product, the area treated and your baby's age and health. The approach in starting tretinoin on sensitive skin applies once it has been cleared. Oral isotretinoin is not used during breastfeeding. Avoid applying any retinoid over cracked or irritated skin, where more is absorbed and it will sting. Professional treatments are a separate question: a systematic review judged most cosmetic procedures compatible with lactation, while noting that the evidence consists largely of case reports and series (Trivedi 2017).
Also stop retinoids if you are trying to conceive or could be pregnant again. Ovulation can return before the first period after birth, and breastfeeding alone is not reliable contraception once feeds become less frequent.
See your physician if postpartum acne is deep, painful or scarring, if a rash on the breast or nipple does not settle (it can be dermatitis, a yeast infection or mastitis, and each is treated differently), or if your baby develops a rash on skin that touches yours. Sudden, severe itching, blisters or a widespread rash also need medical assessment. Decisions about medication while breastfeeding belong to your physician, dermatologist or pharmacist, who can check the specific product against your baby's situation.
The absorption studies are small, used healthy volunteers and measured blood rather than milk (Latriano 1997; Nohynek 2006). A reference review for dermatologists notes that lactation safety data for skin medications are limited and hard to find, and bases its recommendations on the available evidence rather than on trials in breastfeeding women (Butler 2014). Nobody runs trials that expose breastfeeding infants on purpose, so the answer rests on pharmacology: low absorption, no change in blood levels, and a nutrient already present in milk. That supports a cautious yes for cosmetic retinol on the face, not a blanket clearance for every retinoid product. This article is educational and is not a diagnosis or a substitute for care from a physician, pharmacist or dermatologist.
Literature retrieved from PubMed.
Clara Song is the founder and in-house formulator of COMPLETE ELIXIR and a trained medical aesthetician who builds routines for skin that reacts easily; you can read about her background on her profile page. If you are breastfeeding and unsure which of your products to keep, pause or restart, email info@completeelixir.com with your current product list and how your skin has changed since the birth. She will reply with a conservative order for bringing things back, and flag anything that should go to your physician or pharmacist first.
For more on caring for skin that reacts easily, visit the Sensitive and Reactive Skin Resource Centre.
Written and reviewed by Clara Song, Ph.D.
Founder and in-house formulator, COMPLETE ELIXIR
Ph.D. in Data Science · Medical Aesthetician Diploma
Last reviewed: October 6, 2026
This article distinguishes ingredient evidence, formulation rationale, finished-product evidence and professional observation. It is educational and does not replace medical diagnosis or treatment.
October 07, 2026
October 07, 2026
October 07, 2026
